Legacy Wealth Management (Mississippi)’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$255K Buy
1,014
+80
+9% +$17.2K 0.07% 107
2026
Q1
$203K Sell
934
-18
-2% -$3.99K 0.06% 103
2025
Q4
$218K Buy
952
+68
+8% +$15.5K 0.06% 98
2025
Q3
$205K Buy
+884
New +$180K 0.06% 91
2025
Q2
Sell
-1,111
Closed -$233K 91
2025
Q1
$233K Sell
1,111
-103
-8% -$20K 0.08% 90
2024
Q4
$216K Sell
1,214
-409
-25% -$75.2K 0.09% 87
2024
Q3
$321K Buy
+1,623
New +$303K 0.12% 84

Other funds holding ABBV

Legacy Wealth Management (Mississippi)'s ABBV Position: Q2 2026 in Review

Legacy Wealth Management (Mississippi) increased its AbbVie (ABBV) stake by 8.6% in Q2 2026, buying an estimated $17.2K and bringing the position to 1,014 shares worth $255K. The position accounts for 0.07% of the portfolio, ranked #107.

Legacy Wealth Management (Mississippi) first reported a position in ABBV in Q3 2024 and has held it in 7 quarters since. The position peaked at $321K in Q3 2024. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Legacy Wealth Management (Mississippi) held 1,014 shares of AbbVie worth $255K as of Q2 2026.
  • Legacy Wealth Management (Mississippi) bought 80 AbbVie shares in Q2 2026, an estimated $17.2K.
  • AbbVie made up 0.07% of Legacy Wealth Management (Mississippi)'s portfolio in Q2 2026, its #107 holding.
  • Legacy Wealth Management (Mississippi) first reported a position in AbbVie in Q3 2024 and has held it in 7 quarters since.
  • Legacy Wealth Management (Mississippi)'s AbbVie position peaked at $321K in Q3 2024.
  • 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Legacy Wealth Management (Mississippi)'s 13F filing for Q2 2026, filed 8 Jul 2026.